- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Non-radiographic axial spondyloarthritis
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1536KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 246KB)
Secukinumab – November 2020
Secukinumab: Injection 150 mg in 1 mL pre-filled pen; Cosentyx®
Last updated
5 March 2021